UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000002095
Receipt No. R000002558
Scientific Title Phase II study of cisplatin, docetaxel, and irinotecan, followed by gefitinib, gemcitabine and vinorelbine for patients with non-small-cell lung cancer harboring active EGFR gene mutations (OLCSG0704)
Date of disclosure of the study information 2009/08/01
Last modified on 2015/12/20 10:52:18

No. Disposal Last modified on Item of update
1 Insert 2009/06/19 17:29:43
2 Update 2011/12/19 14:03:43 Name of person sending information
Organization
Organization
Division name
Division name
Address
Address
TEL
Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2013/12/19 11:47:44 Email
4 Update 2015/01/08 18:14:37 UMIN ID1
5 Update 2015/12/20 10:52:18 Recruitment status
Results


Contact us.